E-Prescribing Market Trends

  • Report ID: 4611
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

E-Prescribing Market Trends

Growth Drivers

  • Growing Prevalence of Drug Abuse – It is observed that e-prescriptions can reduce drug abuse among healthcare providers and common citizens. It limits the diversion of drugs and can expose the healthcare providers involved in the drug prescription for non-medical use. Hence, governments of nations are being more active to accelerate the adoption of electronic prescriptions. Therefore, such benefits and rising government initiatives are projected to hike market growth over the forecast period.
  • Statistics show that over 60% of American adults use prescribed medicines, while 3 in 20 teenagers have used a drug without a prescription. Drug abuse has been reported to cost the United States more than $750 billion annually in costs associated with crime, compromised productivity, and healthcare.
  • Medication Errors Caused by Poorly Communicated Prescriptions – On average, over 98000 reported cases of possible medication errors are reported to the FDA in the United States.

  •  Escalation in the Adoption of an Electronic Health Record (EHR) System - It is a patient-centered, real-time record-keeping system that securely and promptly makes information accessible to authorized users. 89.9% of office-based physicians and 86% of non-Federal general acute care hospitals have globally adopted EHR in the last few years.

  • Rising Cases of Incidence of Chronic Diseases - as a result of which, medical institutions are under pressure to efficiently administer and treat the increased prevalence of these conditions. According to the CDC, 12 out of every 20 people in the US have a chronic illness. The prevalence of these conditions is projected to directly aid the expansion of the e-prescribing market in the forecasted period.

Challenges

  • Low Research and Development Investment in Technology in Underdeveloped Countries – resulting in a limited supply of skilled labor caused by low enrolment rates in higher education. Inadequate or unstable policy and regulatory environments capable of promoting progress play a key role in the poor state of science, technology, and innovation in the medical infrastructure of underdeveloped countries.

  • Lack of Network Penetration in Rural Areas
  • High Initial Cost of Installation

E-Prescribing Market: Key Insights

Base Year

2022

Forecast Year

2023-2033

CAGR

~20%

Base Year Market Size (2022)

~ USD 2 Billion

Forecast Year Market Size (2033)

~ USD 10 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

20.2%

Base Year Market Size (2024)

USD 2.87 billion

Forecast Year Market Size (2037)

USD 31.59 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4611
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of e-prescribing is evaluated at USD 3.33 billion.

The e-prescribing market size was valued at USD 2.87 billion in 2024 and is likely to exceed USD 31.59 billion by the end of 2037, expanding at over 20.2% CAGR during the forecast period i.e., between 2025-2037. Medication errors caused by poorly communicated prescriptions will boost the market growth.

North America is projected to hold largest industry share by 2037, attributed to increasing utilization of prescribed medication in the region.

The major players in the market include DrChrono Inc., Allscripts Healthcare Solutions, Inc., EPIC Systems, Inc., NextGen Healthcare, Inc., athenahealth, Inc., MCKESSON CORPORATION, Henry Schein One, LLC, DrFirst.com, Inc., Medical Information Technology, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample